Advances in fluorescence imaging techniques to detect oral cancer and its precursors

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

Bibliography

• 1  Parkin DM, Bray F, Ferlay J, Pisani P: Global Cancer Statistics, 2002. CA Cancer J. Clin.55,74–108 (2005).
  MedlineGoogle Scholar
• 2  Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer Statistics, 2009. CA Cancer J. Clin.59,225–249 (2009).
  MedlineGoogle Scholar
• 3  Garcia M, Jemal A, Ward EM et al.: Global Cancer Facts & Figures 2007. American Cancer Society, GA, USA (2007).
  Google Scholar
• 4  Peterson PE: The World Oral Health Report 2003: continuous improvement of oral health in the 21st Century – the approach of the WHO Global Oral Health Programme. Community Dent. Oral Epidemiol.31(Suppl. 1),3–24 (2003).
  MedlineGoogle Scholar
• 5  Petersen PE: Oral cancer prevention and control – the approach of the World Health Organization. Oral Oncol.45,454–460 (2009).
  MedlineGoogle Scholar
• 6  Scott SE, Grunfeld EA, McGurk M: The idiosyncratic relationship between diagnostic delay and stage of oral squamous cell carcinoma. Oral Oncol.41(4),396–403 (2005).
  Medline CASGoogle Scholar
• 7  Evans SJ, Langdon JD, Rapidis AD, Johnson NW: Prognostic significance of STNMP and velocity of tumor growth in oral cancer. Cancer49(4),773–776 (1982).
  Medline CASGoogle Scholar
• 8  Mashberg A, Samit AM: Early detection, diagnosis, and management of oral and oropharyngeal cancer. CA Cancer J. Clin.39(2),67–88 (1989).
  Medline CASGoogle Scholar
• 9  Spiro RH: Squamous cancer of the tongue. CA Cancer J. Clin.35(4),252–256 (1985).
  Medline CASGoogle Scholar
• 10  Dolan RW, Vaughan CW, Fuleihan N: Symptoms in early head and neck cancer: an inadequate indicator. Otolaryngol. Head Neck Surg.119(5),463–467 (1998).
  Medline CASGoogle Scholar
• 11  Vernham GA, Crowther JA: Head and neck carcinoma – stage at presentation. Clin. Otolaryngol. Allied Sci.19(2),120–124 (1994).
  Medline CASGoogle Scholar
• 12  Day GL, Blot WJ: Second primary tumors in patients with oral cancer. Cancer70(1),14–19 (1992).
  Medline CASGoogle Scholar
• 13  Epstein JB, Sciubba JJ, Banasek TE, Hay LJ: Failure to diagnose and delayed diagnosis of cancer: medicolegal issues. J. Am. Dent. Assoc.140(12),1494–1503 (2009).
  MedlineGoogle Scholar
• 14  Peacock ZS, Pogrel MA, Schmidt BL: Exploring the reasons for delay in treatment of oral cancer. J. Am. Dent. Assoc.139(10),1346–1352 (2008).
  MedlineGoogle Scholar
• 15  Yu T, Wood RE, Tenenbaum HC: Delays in diagnosis of head and neck cancers. J. Can. Dent. Assoc.74(1),61 (2008).
  MedlineGoogle Scholar
• 16  Allison P, Locker D, Feine JS: The role of diagnostic delays in the prognosis of oral cancer: a review of the literature. Oral Oncol.34(3),161–170 (1998).
  Medline CASGoogle Scholar
• 17  Fortin A, Bairati I, Albert M, Moore L, Allard J, Couture C: Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.52(4),929–936 (2002).
  MedlineGoogle Scholar
• 18  Downer MC, Moles DR, Palmer S, Speight PM: A systemic review of test performance in screening for oral cancer and precancer. Oral Oncol.40,264–273 (2004).▪ Reviews eight prospective investigations of the performance of visual examination for populations screening for oral cancer and precancer.
  MedlineGoogle Scholar
• 19  Patton LL, Epstein JB, Kerr AR: Adjunctive techniques for oral cancer examination and lesion diagnosis. J. Am. Dent. Assoc.139,896–905 (2008).
  MedlineGoogle Scholar
• 20  Epstein JB, Gorsky M, Lonky S, Silverman S Jr, Epstein JD, Bride M: The efficacy of oral lumenoscopy™ (ViziLite^®) in visualizing oral mucosal lesions. Spec. Care Dentist26(4),171–174 (2006).▪ Multicenter study describing the use of visual examination with chemiluminescent illumination as an adjunct to conventional oral examination. Chemiluminescent examination did not improve visualization of red lesions, but improved the brightness and sharpness of the margins of white lesions and red and white lesions.
  MedlineGoogle Scholar
• 21  Kerr AR, Sirois DA, Epstein JB: Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. J. Clin. Dent.17(3),59–63 (2006).
  Medline CASGoogle Scholar
• 22  Ram S, Siar CH: Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int. J. Oral Maxillofac. Surg.34(5),521–527 (2005).
  Medline CASGoogle Scholar
• 23  Farah CS, McCullough MJ: A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite™) in the visualisation of oral mucosal white lesions. Oral Oncol.43,820–824 (2007).
  Medline CASGoogle Scholar
• 24  Oh ES, Laskin DM: Efficacy of the ViziLite system in the identification of oral lesions. J. Oral Maxillofac. Surg.65(3),424–426 (2007).
  MedlineGoogle Scholar
• 25  De Veld DC, Witjes MJ, Sterenborg HJ, Roodenburg JL: The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol.41,117–131 (2005).
  Medline CASGoogle Scholar
• 26  Roblyer D, Richards-Kortum R, Sokolov K et al.: Multispectral optical imaging device for in vivo detection of oral neoplasia. J. Biomed. Opt.13(2),024019 (2008).
  MedlineGoogle Scholar
• 27  Lane PM, Gilhuly T, Whitehead P et al.: Simple device for the direct visualization of oral-cavity tissue fluorescence. J. Biomed. Opt.11(2),024006 (2006).▪▪ Pilot study describing the performance of an initial version of the VELscope® to discriminate normal oral mucosa from neoplastic lesions based on loss of autofluorescence.
  MedlineGoogle Scholar
• 28  Poh CF, Ng SP, Williams PM et al.: Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck29(1),71–76 (2007).
  MedlineGoogle Scholar
• 29  Kois JC, Truelove E: Detecting oral cancer: A new technique and case reports. Dent. Today25(10), 94, 96–97 (2006).
  Google Scholar
• 30  Poh CF, Williams PM, Zhang L, Rosin MP: Heads up! – A call for dentists to screen for oral cancer. J. Can. Dent. Assoc.72(5),413–416 (2006).
  MedlineGoogle Scholar
• 31  Westra WH, Sidransky D: Fluorescence visualization in oral neoplasia: shedding light on an old problem. Clin. Cancer Res.12(22),6594–6597 (2006).
  Medline CASGoogle Scholar
• 32  Laronde DM, Poh CF, Williams PM et al.: A magic wand for the community dental office? Observations from the British Columbia Oral Cancer Prevention Program. J. Can. Dent. Assoc.73(7),607–609 (2007).
  MedlineGoogle Scholar
• 33  Rosin MP, Poh CF, Guillard M, Williams PM, Zhang L, MacAulay C: Visualization and other emerging technologies as change makers for oral cancer prevention. Ann. NY Acad. Sci.1098,167–183 (2007).
  Medline CASGoogle Scholar
• 34  Williams PM, Poh CF, Hovan AJ, Ng S, Rosin MP: Evaluation of a suspicious oral mucosal lesion. J. Can. Dent. Assoc.74(3),275–280 (2008).
  MedlineGoogle Scholar
• 35  Rosin MP, Poh CF, Elwood JM et al.: New hope for an oral cancer solution: together we can make a difference. J. Can. Dent. Assoc.74(3),261–266 (2008).
  MedlineGoogle Scholar
• 36  Paulis M: The influence of patient education by the dental hygienist: acceptance of the fluorescence oral cancer exam. J. Dent. Hygiene83(3),134–140 (2009).
  Google Scholar
• 37  Kalmar JR: Advances in the detection and diagnosis of oral precancerous and cancerous lesions. Oral Maxillofac. Surg. Clin. N. Am.18,465–482 (2006).
  MedlineGoogle Scholar
• 38  Kelloff GJ, Sullivan DC, Baker H et al.: Workshop on imaging science development for cancer prevention and preemption. Cancer Biomark.3,1–33 (2007).
  MedlineGoogle Scholar
• 39  Lingen MW: Oral cancer screening aids: where is the science? Oral Surg. Oral Med. Oral Path. Oral Rad. Oral Endo.103(2),153–154 (2007).
  MedlineGoogle Scholar
• 40  Lingen MW, Kalmar JR, Karrison T, Speight PM: Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol.44(1),10–22 (2007).▪ Review of the literature describing the performance of oral cancer screening adjuncts including toluidine blue, brush cytology, tissue reflectance and autofluorescence, concluding that well-designed clinical studies are needed to assess the utility of these diagnostic aids to detect oral lesions unseen by conventional examination.
  MedlineGoogle Scholar
• 41  Trullenque-Eriksson A, Muñoz-Corcuera M, Campo-Trapero J, Cano-Sánchez J, Bascones-Martínez A: Analysis of new diagnostic methods in suspicious lesions of the oral mucosa. Med. Oral Patol. Oral Cir. Bucal.14(5),E210–E216 (2009).
  MedlineGoogle Scholar
• 42  Rhodus NL: Oral cancer and precancer: improving outcomes. Compend. Contin. Educ. Dent.30(8),486–488, 490–494, 496–498 (2009).
  MedlineGoogle Scholar
• 43  Fedele S: Diagnostic aids in the screening of oral cancer. Head Neck Oncol.1(1),5 (2009).
  MedlineGoogle Scholar
• 44  Balevi B: Evidence-based decision-making: should the general dentist adopt the use of the VELscope for routine screening for oral cancer? J. Can. Dent. Assoc.73(7),603–606 (2007).
  MedlineGoogle Scholar
• 45  Huber MA: Assessment of the VELscope as an adjunctive examination tool. Tex. Dent. J.126(6),528–535 (2009).
  MedlineGoogle Scholar
• 46  Mehrotra R, Singh M, Thomas S et al.: A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J. Am. Dent. Assoc.141(2),151–156 (2010).
  MedlineGoogle Scholar
• 47  Missmann M, Jank S, Laimer K, Gassner R: A reason for the use of toluidine blue staining in the presurgical management of patients with oral squamous cell carcinomas. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.102,741–743 (2006).
  MedlineGoogle Scholar
• 48  Kerawala CJ, Beale V, Reed M, Martin IC: The role of vital tissue staining in the marginal control of oral squamous cell carcinoma. Int. J. Oral Maxillofac. Surg.29,32–35 (2000).
  Medline CASGoogle Scholar
• 49  Poh CF, Zhang L, Anderson DW et al.: Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin. Cancer Res.12(22),6716–6722 (2006).▪ Exploratory study using the VELscope to assess whether alterations in autofluorescence around oral cancers correspond to subclinical field changes. Loss of fluorescence was found to extend beyond the clinical margin and was associated with dysplasia and loss of heterozygosity at 3p and/or 9p.
  Medline CASGoogle Scholar
• 50  Poh CF, MacAulay CE, Zhang L, Rosin MP: Tracing the “at-risk” oral mucosa field with autofluorescence: steps toward clinical impact. Cancer Prev. Res.2(5),401–404 (2009).▪▪ Examines the rate of recurrence for oral cancer patients whose lesions were resected with standard visual guidance versus autofluorescence image guidance. With a minimum 12-month follow-up, 32% of the 22 control-group patients experienced recurrence, while none of the 38 fluorescence-guided patients experienced recurrence.
  MedlineGoogle Scholar
• 51  Roblyer D, Kurachi C, Stepanek V et al.: Objective detection and delineation of oral neoplasia using autofluorescence imaging. Cancer Prev. Res.2(5),423–431 (2009).▪▪ Describes the use of digital fluorescence imaging to identify the presence and boundaries of oral neoplastic lesions in a training and validation data set; digital fluorescence images are analyzed to produce disease-probability maps indicating the likelihood of neoplasia.
  MedlineGoogle Scholar
• 52  Pavlova I, Williams M, El-Naggar A, Richards-Kortum R, Gillenwater A: Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Clin. Cancer Res.14(8),2396–2404 (2008).▪ Confocal fluorescence microscopy of fresh organ cultures of oral mucosa is used to document the biological basis for differences in autofluorescence of normal, inflammatory and neoplastic oral tissue.
  MedlineGoogle Scholar
• 53  Pavlova I, Weber CR, Schwarz RA et al.: Monte Carlo model to describe depth selective fluorescence spectra of epithelial tissue: applications for diagnosis of oral precancer. J. Biomed. Opt.13(6),064012 (2008).
  MedlineGoogle Scholar
• 54  Pavlova I, Weber CR, Schwarz RA, Williams MD, Gillenwater AM, Richards-Kortum R: Fluorescence spectroscopy of oral tissue: Monte Carlo modeling with site-specific tissue properties. J. Biomed. Opt.14(1),014009 (2009).
  MedlineGoogle Scholar
• 55  Dwyer PJ, DiMarzio CA, Rajadhyaksha M: Confocal q line-scanning microscope for imaging human tissues. Appl. Optics46(10),1843–1851 (2007).
  MedlineGoogle Scholar
• 56  Shin H-J, Pierce MC, Lee D, Ra H, Solgaard O, Richards-Kortum R: Fiber-optic confocal microscope using a MEMS scanner and miniature objective lens. Opt. Express.15(15),9113–9122 (2007).
  MedlineGoogle Scholar
• 57  Maitland KC, Gillenwater AM, Williams MD, El-Naggar AK, Descour MR, Richards-Kortum RR: In vivo imaging of oral neoplasia using a miniaturized fiber optic confocal reflectance microscope. Oral Oncol.44(11),1059–1066 (2008).
  MedlineGoogle Scholar
• 58  Thong PS, Olivo M, Kho K-W et al.: Laser confocal endomicroscopy as a novel technique for fluorescence diagnostic imaging of the oral cavity. J. Biomed. Opt.12(1),014007 (2007).
  MedlineGoogle Scholar
• 59  Haxel BR, Goetz M, Kiesslich R, Gosepath J: Confocal endomicroscopy: a novel application for imaging of oral and oropharyngeal mucosa in human. Eur. Arch. Otorhinolaryngol.267(3),443–448 (2010).
  MedlineGoogle Scholar
• 60  Muldoon TJ, Pierce MC, Nida DL, Williams MD, Gillenwater A, Richards-Kortum R: Subcellular-resolution molecular imaging within living tissue by fiber microendoscopy. Opt. Express.15(25),16413–16423 (2007).▪▪ Describes a novel high-resolution fluorescence imaging system to image changes in nuclear size and density in oral mucosa associated with neoplasia.
  Medline CASGoogle Scholar
• 61  Carlson AL, Coghlan LG, Gillenwater AM, Richards-Kortum RR: Dual-mode reflectance and fluorescence near-video-rate confocal microscope for architectural, morphological and molecular imaging of tissue. J. Microsc.228(1),11–24 (2007).
  MedlineGoogle Scholar
• 62  Carlson AL, Gillenwater AM, Williams MD, El-Naggar AK, Richards-Kortum RR: Confocal microscopy and molecular-specific optical contrast agents for the detection of oral neoplasia. Tech. Canc. Res. Treat.6(5),361–374 (2007).
  MedlineGoogle Scholar